Labnovation Technologies, Inc.
| Payment Terms | D/A, D/P, T/T |
| Supply Ability | 500000/Day |
| Delivery Time | 5-7 work day |
| Packaging Details | Carton |
| Specimen | Nasopharyngeal Swabs, Oropharyngeal Swabs |
| Test Speed | within 15-20minutes |
| Package | 20 Test/Box |
| Storage | 2℃-30℃ |
| Warranty | 18 Months |
| Specificity | >90% |
| Sensitivity | >90% |
| Brand Name | LABNOVATION |
| Model Number | LX-401401 |
| Certification | ISO13485, ISO9001, CE |
| Place of Origin | China |
View Detail Information
Explore similar products
High Accuracy White Influenza AB Test Kit Immunochromatography
ISO SARS-CoV-2 Antigen Influenza AB Test Kit Professional
ODM Oropharyngeal Swab Influenza Antigen Test Kit ISO13485
Professional OP Antigen Influenza AB Test Kit 15 Minute Lateral Flow Test Box
Product Specification
| Payment Terms | D/A, D/P, T/T | Supply Ability | 500000/Day |
| Delivery Time | 5-7 work day | Packaging Details | Carton |
| Specimen | Nasopharyngeal Swabs, Oropharyngeal Swabs | Test Speed | within 15-20minutes |
| Package | 20 Test/Box | Storage | 2℃-30℃ |
| Warranty | 18 Months | Specificity | >90% |
| Sensitivity | >90% | Brand Name | LABNOVATION |
| Model Number | LX-401401 | Certification | ISO13485, ISO9001, CE |
| Place of Origin | China | ||
| High Light | OEM government lateral flow test kits ，government lateral flow test kits 90% ，One Step lateral flow test pack | ||
Rapid Test Kit Rapid Antigen Test SARS-CoV-2 Antigen & Influenza A/B Rapid Test
Intended Use
The SARS-CoV-2 Antigen & Influenza A/B Rapid Test Kit
(Immunochromatography) is a lateral flow chromatography immunoassay intended for the qualitative detection and differentiation of nucleocapsid protein antigens from SARS-CoV-2, influenza type A and influenza type B in the same time directly from nasal/nasopharyngeal (NS/NP) swab, oropharyngeal (OP) swab and saliva specimens from patients with signs and symptoms of respiratory viral infection. It is for professional use only. It is an aid in the diagnosis of the patients with suspected SARS-CoV-2 or influenza infection in conjunction with clinical presentation and results of other laboratory tests. Results from this test kit should not be used as the sole basis for diagnosis.
Negative results should be treated as presumptive and confirmed by viral culture or a molecular assay. Negative results do not rule out COVID-19 and influenza virus infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. The kit is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings. For prescription use only. For in vitro diagnostic use only.
Specification
| Item | Antigen test strip performance against PCR | Influenza A test strip performance against PCR | Influenza B test strip performance against PCR |
| Sensitivity | 98.03% | 93.3% | 97.00% |
| Specificity | 100.00% | 91.00% | 96.40% |
Main Components
Use Step
Apply 2 full drops of the treated sample (60μl-70μl) vertically into each of the two sample wells of the test cassette.
Observe the test results immediately within 15~20 minutes, the result is invalid over 20 minutes.
Interpretation Of Result
POSITIVE: The presence of T (T on nCoV /A or B on Flu) and C lines within the reaction window indicate a positive result on SARS-CoV-2 or Flu A and/or B infection or co-infection.
NEGATIVE: One colored line appears in the control region(C). No apparent colored line appears in the test region (T on nCoV /A or B on Flu). The negative result does not indicate the absence of analytes in the sample, it only indicates the level of tested analytes in the sample is less than the minimum detection limit
INVALID: No colored lines appear, or control line fails to appear, indicating that the operator error or reagent failure. Verify the test procedure and repeat the test with a new testing device.
Feature
Company Details
Business Type:
Manufacturer
Year Established:
2001
Total Annual:
10000000-50000000
Employee Number:
100~600
Ecer Certification：
Active Member
Labnovation Technologies, Inc. is an original manufacturer established in Shenzhen, China since 2001. We are dedicated in developing and manufacturing IVD instruments and reagents including HbA1c analyzer and reagents, rapid test reader & reagents, hematology reagents, clinical chemistry reagent... Labnovation Technologies, Inc. is an original manufacturer established in Shenzhen, China since 2001. We are dedicated in developing and manufacturing IVD instruments and reagents including HbA1c analyzer and reagents, rapid test reader & reagents, hematology reagents, clinical chemistry reagent...
Get in touch with us
Leave a Message, we will call you back quickly!